top of page

A L T I T U D E

Life Science Ventures

Indigo Agriculture CEO: Changing Economics for Farmers | Mad Money | CNBC

May 25, 2018
0 min read

https://www.youtube.com/watch?v=Xk0iWeBN_-U

Comments

Featured Posts

Indigo Ag announces an additional $360M in financing, appoints Stéphane Bancel, Moderna CEO, to Boar

Sana Biotechnology Announces Completion of Initial Financing

Recent Posts

Before eyeing a Nasdaq ticker, AI drug discovery specialist Generate already attracted interest from Amgen and Novartis

‘The perfect partner’: Astellas, Vir engage in $1.7B deal for masked prostate cancer bispecific

TSRA-196 AATD receives Fast Track and Orphan Drug designation from the FDA

Tessera Therapeutics Announces FDA Clearance of IND Application for its Lead In Vivo Gene Editing Program TSRA-196 for AATD

Lyell Immunopharma Presents New Clinical Data from Ongoing Trial of Ronde-Cel Showing High Rates of Durable Complete Responses in Patients with Large B-cell Lymphoma at the 67th ASH Annual Meeting

Encoded Therapeutics Presents Positive Interim Efficacy Data from Initial Dose Levels of Phase 1/2 Trials Evaluating ETX101 Gene Therapy in Dravet Syndrome

Nuvation Bio Announces Publication of Positive Phase 2 Study Results for Safusidenib for the Treatment of Grade 2 IDH1-Mutant Glioma in Neuro-Oncology

Regeneron and Tessera Therapeutics to Jointly Develop TSRA-196, an Investigational Gene Editing Therapy for Alpha-1 Antitrypsin Deficiency (AATD)

Announcing Lila’s $350M Series A and Incredible Partners on Our Mission

Nuvation Bio Enrolls First Patient in TRUST-IV Phase 3 Study of IBTROZI™ (taletrectinib) for the Adjuvant Treatment of ROS1-Positive Early-Stage Non-Small Cell Lung Cancer

Archive

bottom of page